MXBIO

Seoul, South Korea · Founded 2018 · Privately Held (backing)

Developer of periodontal disease treatment drugs designed to offer periodontal disease treatment. MXBIO is based in Seoul, South Korea and was founded in 2018. It has raised $3.2 million.

Last price · $/share
—
Implied valuation
—
Total raised
$3.2M
Last round
—

Who backs MXBIO?

9 investors
InvestorType
Tech Incubator Program for StartupOther
Posco InvestmentVenture capital
Shinhan CapitalOther
KB SecuritiesOther
A VenturesVenture capital
BiiG WAVEOther
Korea SMEs and Startups AgencyOther
CKD Venture Capital—
HB Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MXBIO investors

9 investors are on record for MXBIO, including Tech Incubator Program for Startup, Posco Investment, Shinhan Capital and KB Securities.

Free account
More of MXBIO with a free account
  • ·Watch MXBIO: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like MXBIO. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View